Repligen Financials

Repligen Stock Summary

Repligen competes with ORMAT TECHNOLOGIES, Agilent Technologies, BioNTech, Easy Software, and CPU SOFTWAREHOUSE. Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people.

Repligen Key Financial Ratios

There are many critical financial ratios that Repligen's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Repligen reports annually and quarterly.

Repligen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Repligen's current stock value. Our valuation model uses many indicators to compare Repligen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repligen competition to find correlations between indicators driving Repligen's intrinsic value. More Info.Repligen is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about  0.50  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Repligen is roughly  2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repligen's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Repligen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Repligen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Repligen based on widely used predictive technical indicators. In general, we focus on analyzing Repligen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Repligen's daily price indicators and compare them against related drivers.

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.